• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于阿尔茨海默病早期检测和监测的视网膜血管生物标志物。

Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.

机构信息

Commonwealth Scientific and Industrial Research Organisation (CSIRO), Perth, WA, Australia.

出版信息

Transl Psychiatry. 2013 Feb 26;3(2):e233. doi: 10.1038/tp.2012.150.

DOI:10.1038/tp.2012.150
PMID:23443359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3591002/
Abstract

The earliest detectable change in Alzheimer's disease (AD) is the buildup of amyloid plaque in the brain. Early detection of AD, prior to irreversible neurological damage, is important for the efficacy of current interventions as well as for the development of new treatments. Although PiB-PET imaging and CSF amyloid are the gold standards for early AD diagnosis, there are practical limitations for population screening. AD-related pathology occurs primarily in the brain, but some of the hallmarks of the disease have also been shown to occur in other tissues, including the retina, which is more accessible for imaging. Retinal vascular changes and degeneration have previously been reported in AD using optical coherence tomography and laser Doppler techniques. This report presents results from analysis of retinal photographs from AD and healthy control participants from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing. This is the first study to investigate retinal blood vessel changes with respect to amyloid plaque burden in the brain. We demonstrate relationships between retinal vascular parameters, neocortical brain amyloid plaque burden and AD. A number of RVPs were found to be different in AD. Two of these RVPs, venular branching asymmetry factor and arteriolar length-to-diameter ratio, were also higher in healthy individuals with high plaque burden (P = 0.01 and P = 0.02 respectively, after false discovery rate adjustment). Retinal photographic analysis shows potential as an adjunct for early detection of AD or monitoring of AD-progression or response to treatments.

摘要

阿尔茨海默病(AD)最早可检测到的变化是大脑中淀粉样斑块的堆积。在不可逆的神经损伤之前,早期发现 AD 对于当前干预措施的疗效以及新疗法的开发都很重要。虽然 PiB-PET 成像和 CSF 淀粉样蛋白是 AD 早期诊断的金标准,但在人群筛查方面存在实际限制。AD 相关的病理学主要发生在大脑中,但该疾病的一些特征也已在其他组织中显示出来,包括视网膜,视网膜更适合进行成像。先前已经使用光学相干断层扫描和激光多普勒技术在 AD 中报告了视网膜血管变化和退行性变。本报告介绍了来自澳大利亚成像、生物标志物和生活方式(AIBL)老龄化旗舰研究的 AD 和健康对照参与者的视网膜照片分析结果。这是第一项研究,旨在调查与大脑中淀粉样斑块负担有关的视网膜血管变化。我们证明了视网膜血管参数、大脑新皮质淀粉样斑块负担和 AD 之间存在关系。AD 患者存在多种 RVPs 差异。其中两种 RVPs,静脉分支不对称因子和小动脉长度与直径比,在斑块负担高的健康个体中也更高(经假发现率调整后分别为 P = 0.01 和 P = 0.02)。视网膜摄影分析显示出作为 AD 早期检测或 AD 进展或治疗反应监测的辅助手段的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ef/3591002/c7deb70b92f1/tp2012150f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ef/3591002/c8b6ac945e96/tp2012150f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ef/3591002/c7deb70b92f1/tp2012150f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ef/3591002/c8b6ac945e96/tp2012150f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ef/3591002/c7deb70b92f1/tp2012150f2.jpg

相似文献

1
Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.用于阿尔茨海默病早期检测和监测的视网膜血管生物标志物。
Transl Psychiatry. 2013 Feb 26;3(2):e233. doi: 10.1038/tp.2012.150.
2
Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.视网膜血管和结构变化与老年人淀粉样蛋白负荷相关:临床前阿尔茨海默病的眼科生物标志物。
Alzheimers Res Ther. 2017 Mar 1;9(1):13. doi: 10.1186/s13195-017-0239-9.
3
Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.用于阿尔茨海默病早期检测和监测的瞳孔反应生物标志物。
Curr Alzheimer Res. 2013 Nov;10(9):931-9. doi: 10.2174/15672050113106660163.
4
Longitudinal retinal layer changes in preclinical Alzheimer's disease.临床前阿尔茨海默病的视网膜层状变化。
Acta Ophthalmol. 2021 Aug;99(5):538-544. doi: 10.1111/aos.14640. Epub 2020 Oct 18.
5
Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.基底前脑萎缩与阿尔茨海默病中的β淀粉样蛋白负荷相关。
Neuroimage Clin. 2014 Nov 27;7:105-13. doi: 10.1016/j.nicl.2014.11.015. eCollection 2015.
6
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.澳大利亚衰老成像、生物标志物与生活方式(AIBL)研究:针对阿尔茨海默病纵向研究招募的1112名个体的方法及基线特征
Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27.
7
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.阿尔茨海默病标准化脑脊液生物标志物在澳大利亚成像、生物标志物和生活方式(AIBL)研究中经PET淀粉样β蛋白特征化的受试者中得到验证。
J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247.
8
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.血浆 Aβ42/40 比值可检测阿尔茨海默病早期,并与 AB255 研究中的 CSF 和神经影像学生物标志物相关联。
J Prev Alzheimers Dis. 2019;6(1):34-41. doi: 10.14283/jpad.2018.41.
9
Potential Retinal Biomarkers in Alzheimer's Disease.阿尔茨海默病的潜在视网膜生物标志物。
Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834.
10
Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.视网膜病理学作为认知障碍和阿尔茨海默病的生物标志物。
J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25.

引用本文的文献

1
Retinal biomarkers in cognitive impairment and dementia: Structural, functional, and molecular insights.认知障碍和痴呆中的视网膜生物标志物:结构、功能和分子见解。
Alzheimers Dement. 2025 Sep;21(9):e70672. doi: 10.1002/alz.70672.
2
Ocular changes as potential biomarkers for early diagnosis of Alzheimer's disease.眼部变化作为阿尔茨海默病早期诊断的潜在生物标志物。
Alzheimers Dement. 2025 Aug;21(8):e70476. doi: 10.1002/alz.70476.
3
Cerebral Amyloid Deposition With F-Florbetapir PET Mediates Retinal Vascular Density and Cognitive Impairment in Alzheimer's Disease.

本文引用的文献

1
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.为了定义阿尔茨海默病的临床前阶段:来自美国国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议。
Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.
2
Retinal vascular caliber and risk of dementia: the Rotterdam study.视网膜血管口径与痴呆风险:鹿特丹研究。
Neurology. 2011 Mar 1;76(9):816-21. doi: 10.1212/WNL.0b013e31820e7baa. Epub 2011 Feb 2.
3
A new method to measure peripheral retinal vascular caliber over an extended area.
F-氟比他吡PET检测的脑淀粉样蛋白沉积介导阿尔茨海默病患者的视网膜血管密度及认知障碍
Hum Brain Mapp. 2025 Aug 1;46(11):e70310. doi: 10.1002/hbm.70310.
4
Ocular Structural and Vascular Changes in Patients with Severe Asymptomatic Carotid Disease After Undergoing Carotid Endarterectomy (CEA) and Carotid Artery Stenting (CAS).重度无症状性颈动脉疾病患者行颈动脉内膜切除术(CEA)和颈动脉支架置入术(CAS)后的眼部结构和血管变化。
Diagnostics (Basel). 2025 Jul 21;15(14):1826. doi: 10.3390/diagnostics15141826.
5
Visual field defects in dementia: A scoping review.痴呆症中的视野缺损:一项范围综述。
Ophthalmic Physiol Opt. 2025 Sep;45(6):1359-1375. doi: 10.1111/opo.13550. Epub 2025 Jul 26.
6
VascX Models: Deep Ensembles for Retinal Vascular Analysis From Color Fundus Images.VascX模型:用于彩色眼底图像视网膜血管分析的深度集成模型
Transl Vis Sci Technol. 2025 Jul 1;14(7):19. doi: 10.1167/tvst.14.7.19.
7
The Relevance of Optical Coherence Tomography Angiography in Screening and Monitoring Hypertensive Patients with Carotid Artery Stenosis.光学相干断层扫描血管造影术在筛查和监测高血压合并颈动脉狭窄患者中的相关性
Diagnostics (Basel). 2025 May 30;15(11):1393. doi: 10.3390/diagnostics15111393.
8
Retinal Vessel Geometry and Retinal Abnormalities in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病中的视网膜血管几何形态与视网膜异常
Transl Vis Sci Technol. 2025 Jun 2;14(6):17. doi: 10.1167/tvst.14.6.17.
9
Choroidal and retinal vascular changes in adults with Down syndrome: Insights into the Alzheimer's disease continuum.唐氏综合征成年患者的脉络膜和视网膜血管变化:对阿尔茨海默病连续体的见解。
Alzheimers Dement. 2025 May;21(5):e70228. doi: 10.1002/alz.70228.
10
Disruptive resting state networks characterizing depressive comorbidity in Alzheimer's disease and mild cognitive impairment.破坏性行为静息态网络表征阿尔茨海默病和轻度认知障碍中的抑郁共病。
J Alzheimers Dis. 2025 Jul;106(1):18-37. doi: 10.1177/13872877251337770. Epub 2025 May 6.
一种新的方法来测量扩展区域的周边视网膜血管口径。
Microcirculation. 2010 Oct;17(7):495-503. doi: 10.1111/j.1549-8719.2010.00048.x.
4
Ocular biomarkers for early detection of Alzheimer's disease.用于阿尔茨海默病早期检测的眼部生物标志物。
J Alzheimers Dis. 2010;22(1):1-16. doi: 10.3233/JAD-2010-100819.
5
Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.从阿尔茨海默病患者的视网膜中鉴定淀粉样斑块,以及在小鼠模型中对视网膜斑块进行非侵入性体内光学成像。
Neuroimage. 2011 Jan;54 Suppl 1:S204-17. doi: 10.1016/j.neuroimage.2010.06.020. Epub 2010 Jun 13.
6
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.澳大利亚老龄化影像、生物标志物与生活方式(AIBL)研究的淀粉样蛋白成像结果。
Neurobiol Aging. 2010 Aug;31(8):1275-83. doi: 10.1016/j.neurobiolaging.2010.04.007. Epub 2010 May 15.
7
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.阿尔茨海默病的脑脊液和血浆生物标志物。
Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16.
8
Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.老年非痴呆患者颞叶新皮质中的β-淀粉样蛋白负担与海马萎缩有关。
Neurology. 2010 Jan 12;74(2):121-7. doi: 10.1212/WNL.0b013e3181c918b5.
9
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.匹兹堡化合物B成像与从认知正常进展为有症状阿尔茨海默病的预测
Arch Neurol. 2009 Dec;66(12):1469-75. doi: 10.1001/archneurol.2009.269.
10
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.全基因组关联研究确定了CLU和CR1基因中与阿尔茨海默病相关的变异。
Nat Genet. 2009 Oct;41(10):1094-9. doi: 10.1038/ng.439. Epub 2009 Sep 6.